AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23877013 — intervention group
Group type: COMPARATOR
Intervention: No postoperative residual disease (n=121)
Number of subjects: 191
Study 23877013 — intervention group
Group type: EXPERIMENTAL
Intervention: Extent of surgery
Number of subjects: 191
Study 23877013 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative performance status
Number of subjects: 191
Study 23877013 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative complications
Number of subjects: 191
Study 23877013 — intervention group
Group type: EXPERIMENTAL
Intervention: FIGO stage
Number of subjects: 191
Study 21300516 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowerment group (active-learning, empowerment approach)
Number of subjects: 84
Study 21300516 — intervention group
Group type: COMPARATOR
Intervention: Traditional diabetes education arm (didactic group session)
Number of subjects: 84
Study 18073007 — intervention group
Group type: EXPERIMENTAL
Intervention: Senofilcon A contact lenses (ACUVUE OASYS Brand Contact Lenses with HYDRACLEAR Plus)
Number of subjects: 11
Study 18073007 — intervention group
Group type: COMPARATOR
Intervention: Habitual contact lenses
Number of subjects: 11
Study 18073007 — intervention group
Group type: COMPARATOR
Intervention: No contact lenses
Number of subjects: 11
Study 16858181 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior approach technique (AA group, n = 60)
Number of subjects: 120
Study 16858181 — intervention group
Group type: COMPARATOR
Intervention: Conventional approach technique (CA group, n = 60)
Number of subjects: 120
Study 16858181 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior approach technique (AA group)
Number of subjects: 120
Study 16858181 — intervention group
Group type: COMPARATOR
Intervention: Conventional approach technique (CA group)
Number of subjects: 120
Study 12853996 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation (APC) at 60 W
Number of subjects: 42
Study 12853996 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation (APC) at 50 W
Number of subjects: 42
Study 12853996 — intervention group
Group type: COMPARATOR
Intervention: Argon plasma coagulation (APC)
Number of subjects: 42
Study 11205449 — intervention group
Group type: EXPERIMENTAL
Intervention: Papaverine (5 mg/ml)
Number of subjects: 116
Study 11205449 — intervention group
Group type: EXPERIMENTAL
Intervention: Total pathological skin reactivity to vasomotor agents
Number of subjects: 116
Study 9260089 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary pelvic floor muscle contraction with Conmax
Number of subjects: 12
Study 9260089 — intervention group
Group type: COMPARATOR
Intervention: Vaginal electrical stimulation with Conmax
Number of subjects: 12
Study 9260089 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary pelvic floor muscle contraction with Medicon MS 105
Number of subjects: 12
Study 9260089 — intervention group
Group type: COMPARATOR
Intervention: Vaginal electrical stimulation with Medicon MS 105
Number of subjects: 12
Study 8469323 — intervention group
Group type: EXPERIMENTAL
Intervention: Felbamate (FBM) 3,600 mg/d
Number of subjects: 111
Study 8469323 — intervention group
Group type: COMPARATOR
Intervention: Valproate (VPA) 15 mg/kg/d
Number of subjects: 111
Study 3486877 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 micrograms 24,25‐dihydroxyvitamin D3
Number of subjects: 19
Study 3486877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 31431654 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Family Resource Scale scores at 18 months
Number of subjects: 0
Study 31431654 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor social support
Number of subjects: 0
Study 31431654 — intervention group
Group type: EXPERIMENTAL
Intervention: Least resources and social support
Number of subjects: 0
Study 27603763 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 126
Study 27603763 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based cognitive rehabilitation (CR)
Number of subjects: 126
Study 27603763 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-directed manualized CR
Number of subjects: 126
Study 27603763 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated therapist-directed CR with cognitive-behavioral psychotherapy (CBT)
Number of subjects: 126
Study 26866767 — intervention group
Group type: EXPERIMENTAL
Intervention: Transtheoretical model (TTM) behavior change constructs
Number of subjects: 1050
Study 22422082 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone nano-bubble water (NBW3) irrigation as an adjunct to mechanical debridement
Number of subjects: 22
Study 22422082 — intervention group
Group type: COMPARATOR
Intervention: Full-mouth mechanical debridement with tap water (WATER)
Number of subjects: 22
Study 22806257 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention targeting fruit and vegetable consumption, red meat consumption, multivitamin intake, and physical activity
Number of subjects: 850
Study 22806257 — intervention group
Group type: EXPERIMENTAL
Intervention: High workplace social capital
Number of subjects: 850
Study 19939247 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized patient
Number of subjects: 5
Study 19939247 — intervention group
Group type: COMPARATOR
Intervention: Mannequin
Number of subjects: 5
Study 17710973 — intervention group
Group type: EXPERIMENTAL
Intervention: Hib‐TT Hiberix mixed with GPO's DTPw vaccine (group 1)
Number of subjects: 360
Study 17710973 — intervention group
Group type: EXPERIMENTAL
Intervention: Hib‐TT mixed with GPO's DTPw vaccine (group 2)
Number of subjects: 360
Study 17710973 — intervention group
Group type: EXPERIMENTAL
Intervention: Hib‐TT mixed with GSK's DTPw vaccine (Tritanrix; group 3)
Number of subjects: 360
Study 17710973 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 360
Study 15359983 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearance after cimetidine administration
Number of subjects: 40
Study 15359983 — intervention group
Group type: COMPARATOR
Intervention: Estimated creatinine clearance
Number of subjects: 40
Study 15359983 — intervention group
Group type: COMPARATOR
Intervention: Standard creatinine clearance
Number of subjects: 40
Study 15359983 — intervention group
Group type: COMPARATOR
Intervention: Inulin clearance
Number of subjects: 40
Study 12119060 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPIs) - omeprazole, rabeprazole, pantoprazole, or lansoprazole
Number of subjects: 16
Study 12119060 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPIs) - newer PPIs (rabeprazole, pantoprazole, lansoprazole)
Number of subjects: 16
Study 12119060 — intervention group
Group type: COMPARATOR
Intervention: Histamine 2-receptor antagonist (ranitidine)
Number of subjects: 16
Study 12119060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 9796073 — intervention group
Group type: EXPERIMENTAL
Intervention: Local finger cooling at temperatures of 30 degrees C, 20 degrees C, 15 degrees C, and 10 degrees C
Number of subjects: 136
Study 9796073 — intervention group
Group type: EXPERIMENTAL
Intervention: Local finger cooling
Number of subjects: 136
Study 8570369 — intervention group
Group type: EXPERIMENTAL
Intervention: Subject-controlled performance feedback
Number of subjects: 0
Study 8570369 — intervention group
Group type: COMPARATOR
Intervention: 50% relative performance feedback
Number of subjects: 0
Study 8570369 — intervention group
Group type: COMPARATOR
Intervention: Summary performance feedback
Number of subjects: 0
Study 8570369 — intervention group
Group type: COMPARATOR
Intervention: Yoked control group
Number of subjects: 0
Study 8570369 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving no performance feedback
Number of subjects: 0
Study 2403952 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily in the morning
Number of subjects: 248
Study 2403952 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 300 mg once daily at night
Number of subjects: 248
Study 114055 — intervention group
Group type: EXPERIMENTAL
Intervention: Montanoa tomentosa extracts (Zoapatle) administered orally at a daily dose of 1.0 to 1.4 gm-equivalent of dry leaves per kilogram of body weight for two days
Number of subjects: 6
Study 114055 — intervention group
Group type: COMPARATOR
Intervention: Commercial tea (control group) administered orally at the same volume and schedule as Zoapatle extracts
Number of subjects: 6
Study 114055 — intervention group
Group type: EXPERIMENTAL
Intervention: Montanoa tomentosa extracts (Zoapatle)
Number of subjects: 6
Study 31415092 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided dry needling (DN) of the piriformis muscle, 3 sessions
Number of subjects: 32
Study 31415092 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 32
Study 28836340 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic alert system (e-alert) with Geneva Risk Score calculation tool
Number of subjects: 1593
Study 28836340 — intervention group
Group type: COMPARATOR
Intervention: Control group (no alert issued)
Number of subjects: 1593
Study 28836340 — intervention group
Group type: EXPERIMENTAL
Intervention: Alert group with no score calculation or inconsistent score result
Number of subjects: 1593
Study 26180051 — intervention group
Group type: COMPARATOR
Intervention: Fish oil supplementation, dosage not specified, duration not specified.
Number of subjects: 0
Study 26180051 — intervention group
Group type: COMPARATOR
Intervention: Bacterial lipopolysaccharide (LPS) administration, details not specified.
Number of subjects: 0
Study 23382157 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 4380
Study 23382157 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TS) prophylaxis
Number of subjects: 4380
Study 23382157 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 4380
Study 21368000 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor learning through grasping a robotic arm and guiding a cursor to visual targets for 10 minutes
Number of subjects: 0
Study 21368000 — intervention group
Group type: COMPARATOR
Intervention: Passive experience of limb trajectories matched to those of subjects who actively performed motor learning
Number of subjects: 0
Study 19407947 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (Zhao's Weitiao No. 3, 40 mL twice a day for 30 days, 6 cycles)
Number of subjects: 163
Study 19407947 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (OLF protocol: L-OHP+LV+5-FU for 4-6 cycles)
Number of subjects: 163
Study 18162018 — intervention group
Group type: COMPARATOR
Intervention: Ziprasidone 10-20 mg
Number of subjects: 9
Study 18162018 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine 10 mg
Number of subjects: 9
Study 18162018 — intervention group
Group type: COMPARATOR
Intervention: Aripiprazole 9.75 mg
Number of subjects: 9
Study 18162018 — intervention group
Group type: COMPARATOR
Intervention: Aripiprazole
Number of subjects: 9
Study 18162018 — intervention group
Group type: COMPARATOR
Intervention: Ziprasidone
Number of subjects: 9
Study 18162018 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 9
Study 15313741 — intervention group
Group type: EXPERIMENTAL
Intervention: 13-hour curriculum in which residents practiced teaching and received feedback during 1-hour small-group sessions taught twice monthly for 6 months
Number of subjects: 62
Study 15313741 — intervention group
Group type: COMPARATOR
Intervention: Control group (untrained residents)
Number of subjects: 62
Study 11207174 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ceftriaxone (50 mg/kg once daily) for 10 days
Number of subjects: 220
Study 11207174 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ceftriaxone (50 mg/kg once daily) for 3 days
Number of subjects: 220
Study 11207174 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 220
Study 10198505 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured assessments by practice nurses after a one-day training course
Number of subjects: 0
Study 10198505 — intervention group
Group type: COMPARATOR
Intervention: General practitioners (GPs)
Number of subjects: 0
Study 7851102 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural patients
Number of subjects: 609
Study 7851102 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance abusing patients in rural areas
Number of subjects: 609
Study 7851102 — intervention group
Group type: COMPARATOR
Intervention: Urban patients
Number of subjects: 609
Study 3379230 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind shrimp-food challenge
Number of subjects: 30
Study 3379230 — intervention group
Group type: EXPERIMENTAL
Intervention: Open challenge of 16 whole cooked shrimp
Number of subjects: 30
Study 3379230 — intervention group
Group type: COMPARATOR
Intervention: Placebo challenges
Number of subjects: 30
Study 3379230 — intervention group
Group type: EXPERIMENTAL
Intervention: Shrimp prick skin test
Number of subjects: 30
Study 3379230 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum shrimp RAST percent
Number of subjects: 30
Study 3379230 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite of positive shrimp prick skin test and elevated serum shrimp-specific IgE
Number of subjects: 30
Study 29793715 — intervention group
Group type: EXPERIMENTAL
Intervention: Mock interview session
Number of subjects: 59
Study 28163248 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone
Number of subjects: 200
Study 28163248 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol
Number of subjects: 200
Study 28163248 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 200
Study 25204437 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrostimulation of the K1 acupoint combined with antiemetic tropisetron
Number of subjects: 103
Study 25204437 — intervention group
Group type: COMPARATOR
Intervention: Placebo point electrostimulation combined with antiemetic tropisetron
Number of subjects: 103
Study 23239683 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil (3 g daily for 60 days)
Number of subjects: 21
Study 23239683 — intervention group
Group type: COMPARATOR
Intervention: Control (no supplementation)
Number of subjects: 21
Study 21679476 — intervention group
Group type: COMPARATOR
Intervention: Intervention group (girls)
Number of subjects: 1465
Study 21679476 — intervention group
Group type: COMPARATOR
Intervention: Control group (girls)
Number of subjects: 1465
Study 21679476 — intervention group
Group type: COMPARATOR
Intervention: Intervention group (boys)
Number of subjects: 1465
Study 21679476 — intervention group
Group type: COMPARATOR
Intervention: Control group (boys)
Number of subjects: 1465
Study 18227852 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective electrical stimulation group (ESG)
Number of subjects: 10
Study 18227852 — intervention group
Group type: COMPARATOR
Intervention: Placebo-controlled group (PG)
Number of subjects: 10
Study 16824996 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler tissue imaging (DTI)
Number of subjects: 278
Study 16824996 — intervention group
Group type: COMPARATOR
Intervention: Pulsed wave Doppler
Number of subjects: 278
Study 16824996 — intervention group
Group type: COMPARATOR
Intervention: Color M-mode (CMM)
Number of subjects: 278
Study 14625334 — intervention group
Group type: EXPERIMENTAL
Intervention: High-energy ESWT
Number of subjects: 144
Study 14625334 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy ESWT
Number of subjects: 144
Study 14625334 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (placebo)
Number of subjects: 144
Study 14625334 — intervention group
Group type: EXPERIMENTAL
Intervention: High-energy ESWT and Low-energy ESWT
Number of subjects: 144
Study 11092294 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,800 IU vitamin E therapy
Number of subjects: 20
Study 11092294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9062860 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan at 0.125%-1% in absolute alcohol (experiment 1)
Number of subjects: 33
Study 9062860 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan at 0.5% in various solvents (experiment 2)
Number of subjects: 33
Study 9062860 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan at 0.5% in various solvents (experiment 3)
Number of subjects: 33
Study 9062860 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (negative control in experiments 2 and 3)
Number of subjects: 33
Study 9062860 — intervention group
Group type: COMPARATOR
Intervention: Absolute alcohol (positive control in experiments 2 and 3)
Number of subjects: 33
Study 8072836 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose RSV immunoglobulin (RSVIG)
Number of subjects: 249
Study 2553511 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium hydroxide
Number of subjects: 64
Study 2553511 — intervention group
Group type: COMPARATOR
Intervention: Bulk laxative (plantago rind and sorbitol)
Number of subjects: 64
Study 360231 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserine (ORG GB 94)
Number of subjects: 0
Study 360231 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study 31626301 — intervention group
Group type: EXPERIMENTAL
Intervention: Operant learning group
Number of subjects: 69
Study 31626301 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy conservation group
Number of subjects: 69
Study 30317839 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive demanding task (Stroop) for 60 min
Number of subjects: 13
Study 30317839 — intervention group
Group type: COMPARATOR
Intervention: Control condition (equivalent time without cognitive task)
Number of subjects: 13
Study 28613956 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib 24 mg/day
Number of subjects: 392
Study 26931362 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive outreach intervention (tailored mailings and telephone calls) with free cessation treatment (nicotine replacement therapy and intensive telephone counselling)
Number of subjects: 2406
Study 26931362 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive outreach intervention
Number of subjects: 2406
Study 26931362 — intervention group
Group type: COMPARATOR
Intervention: Usual care (access to a primary care physician, insurance coverage of FDA-approved smoking cessation medications, and the state's telephone quitline)
Number of subjects: 2406
Study 26931362 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2406
Study 23581280 — intervention group
Group type: EXPERIMENTAL
Intervention: AMICUS
Number of subjects: 30
Study 23581280 — intervention group
Group type: COMPARATOR
Intervention: COBE Spectra
Number of subjects: 30
Study 21802078 — intervention group
Group type: COMPARATOR
Intervention: Standard-definition white-light (SD-WL) colonoscopy
Number of subjects: 630
Study 21802078 — intervention group
Group type: COMPARATOR
Intervention: High-definition white-light (HD-WL) colonoscopy
Number of subjects: 630
Study 21802078 — intervention group
Group type: COMPARATOR
Intervention: Narrow-band imaging (NBI) colonoscopy
Number of subjects: 630
Study 19635962 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime 2 g three times a day
Number of subjects: 49
Study 19635962 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime 6 g per day continuously
Number of subjects: 49
Study 19635962 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime (general)
Number of subjects: 49
Study 16430548 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine
Number of subjects: 60
Study 16430548 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine
Number of subjects: 60
Study 15307988 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinoscopy of combined positive cylinders with negative cylinders (experiment group)
Number of subjects: 189
Study 15307988 — intervention group
Group type: COMPARATOR
Intervention: Conventional retinoscopy (control group)
Number of subjects: 189
Study 11380911 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional IVIG treatment (1 g/kg)
Number of subjects: 35
Study 11380911 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid pulse therapy
Number of subjects: 35
Study 8946097 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol pellet gum
Number of subjects: 510
Study 8946097 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorbitol pellet gum
Number of subjects: 510
Study 8946097 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol stick gum
Number of subjects: 510
Study 8946097 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorbitol stick gum
Number of subjects: 510
Study 8946097 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol/sorbitol mixtures in pellet form
Number of subjects: 510
Study 8946097 — intervention group
Group type: COMPARATOR
Intervention: No gum
Number of subjects: 510
Study 1827003 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine 2.5 mg twice daily
Number of subjects: 187
Study 1827003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study 7043448 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene
Number of subjects: 22
Study 7043448 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined clomiphene-parlodel treatment
Number of subjects: 22
Study 7043448 — intervention group
Group type: COMPARATOR
Intervention: Parlodel
Number of subjects: 22
Study 30381412 — intervention group
Group type: EXPERIMENTAL
Intervention: Patiromer 8.4 g once daily without/with food for 4 weeks
Number of subjects: 112
Study 28984632 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol 600 mg orally administered on the day before PCI and on the day of PCI
Number of subjects: 254
Study 28984632 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no allopurinol pretreatment)
Number of subjects: 254
Study 28984632 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 254
Study 28984632 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study 26523821 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatrician-only SBIRT implementation
Number of subjects: 1871
Study 26523821 — intervention group
Group type: EXPERIMENTAL
Intervention: Embedded BHCP SBIRT implementation
Number of subjects: 1871
Study 23640923 — intervention group
Group type: COMPARATOR
Intervention: Recombinant lipocalin-2 (rLcn2) injected into chow-fed mice
Number of subjects: 0